Industry committee  But when the rules were followed it worked in 60 days. Thank you.

Industry committee  I'm perplexed that they're holding off. I am very perplexed. The generic companies are sitting back and telling Canada that unless parliamentarians change this law, they will not use it again. I find that kind of positioning, when we're talking about this kind of humanitarian cau

Industry committee  Can I jump in here, Mr. Masse, if it's all right?

Industry committee  This presumes that IP is a barrier and you're presuming that weakening IP in this country is going to facilitate access to medicines. I don't believe that. I think what we have to work very carefully on here is that unintended consequences could be quite serious. I identified som

Industry committee  Just very briefly, what we said was that we are voluntarily collaborating internationally, and absolutely with generics, and that has proven to be far more effective. That partnership is the solution, but it's voluntary. We're very proud of the donations we make and we've made th

Industry committee  Absolutely. I think some of the criticisms about CAMR would be a little more credible if there had been a second application, or a third application, and it hadn't worked. At least Apotex moved forward on the first one, and that should be duly noted. Where has everybody else been

Industry committee  There's been speculation that it's price negotiations, etc., but we don't know that. What we can clearly say, and we have all the dates documented and have submitted the documentation to the Senate committee, is that it took 68 days of CAMR. All the delays, whatever the causes we

Industry committee  Thank you, honourable members. We are very pleased to join you today. I hope that we can contribute to the discussion and that the debate generated will be conducive to progress and innovation in access to medicines for developing countries. I agree with the opinions shared toda

Health committee  Madam Chair, actually, I would like to respond--really quite quickly--that we have been constantly in conversation with the industry department. We are constantly.... I wanted to clarify that.

Health committee  Well, if you want to go back and forth, but—

Health committee  Well, very clearly—and I actually do want to debate health care and do believe that—

Health committee  I'm an ex-parliamentarian too, so I—

Health committee  I very much believe that if we protect IP and at the same time ensure that we have proper pricing in this country and ensure good access to innovative medicines, we can in fact be an effective interlocutor, if I could say so, on the 10-year plan. I believe that access to innovati

Health committee  We had no consultations on these amendments.

Health committee  That's what I just said.